Welcome to our dedicated page for Carter Bankshares SEC filings (Ticker: CARE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sorting through Carter Bankshares鈥� dense disclosures to pinpoint loan-loss trends or shifts in deposit costs can feel overwhelming. Each quarterly earnings report stretches well past 100 pages, while every 8-K update on problem credits lands without warning. Stock Titan solves this problem by pairing AI-powered summaries with real-time EDGAR feeds, so you understand the numbers behind this Virginia-based community bank before the market reacts.
Need the exact allowance calculation buried in the latest Carter Bankshares quarterly earnings report 10-Q filing? Our engine flags it instantly. Curious whether directors are accumulating shares? Follow Carter Bankshares insider trading Form 4 transactions and receive Carter Bankshares Form 4 insider transactions real-time alerts the moment they post. If you鈥檙e preparing a credit-risk model, the platform links every footnote in the Carter Bankshares annual report 10-K simplified to concise explanations鈥攏o accounting dictionary required.
Below you鈥檒l find every form the bank files, each tagged with an AI digest that answers common search queries such as 鈥淐arter Bankshares SEC filings explained simply鈥� and 鈥渦nderstanding Carter Bankshares SEC documents with AI.鈥� Key use cases include:
- Compare net-interest-margin movements across periods with AI-highlighted trends.
- Track executive pay details in the Carter Bankshares proxy statement executive compensation.
- Monitor credit events via Carter Bankshares 8-K material events explained.
- Dive into insider confidence with Carter Bankshares executive stock transactions Form 4.
- Run quick 鈥淐arter Bankshares earnings report filing analysis鈥� without reading the full PDF.
Whether you鈥檙e an equity analyst, fixed-income investor, or community-bank enthusiast, Stock Titan delivers the depth you need鈥攎inus the document fatigue.
Wendy S. Bell, Senior Executive Vice President and Chief Financial Officer of Carter Bankshares, Inc. (CARE), reported transactions dated 08/26/2025. The filing shows a sale of 250 common shares at $19.54 per share. A separate entry records 100 shares transferred with a $0 price to Jessica Bell DiGiorgio, and an explanatory note states these shares no longer have pecuniary interest due to Jessica no longer being in the household and were disposed into Jessica Bell DiGiorgio鈥檚 name only. The form was signed by an attorney-in-fact.
Catharine L. Midkiff, a director of Carter Bankshares (CARE), reported a sale of 2,000 shares of common stock on 07/30/2025 at approximately $17.76 per share, leaving her with 16,054 shares beneficially owned. The filing notes that 200 of the sold shares matched a purchase on 06/02/2025, producing $258 in short-swing profits that the reporting person voluntarily disgorged to the issuer.
The explanation states the matched sale was inadvertently within six months of the earlier acquisition to the extent of 200 shares and that the reporting person has remedied the matter by returning the realized profits to the company. The Form 4 is signed by an attorney-in-fact.
Carter Bankshares disclosed that Chief Executive Officer Litz H. Van Dyke shared a letter with employees informing them of a recent medical update. The company furnished that letter as Exhibit 99.1 under a Regulation FD disclosure. The filing contains no financial metrics, operating details, transaction information, or statements about changes to leadership, succession plans, or business operations. The report is signed on the company鈥檚 behalf by Chief Financial Officer Wendy S. Bell. The 8-K therefore communicates the CEO鈥檚 employee-facing medical update without providing any information about material impacts to the company鈥檚 financial position or operations.
Carter Bankshares (CARE) director James W. Haskins reported an open-market sale of 2,000 common shares on 07/28/2025 at $17.84 each.
- Gross proceeds: 鈮�$35,680.
- Post-sale holdings: 61,900 shares held directly and 1,751 shares held indirectly through his spouse.
- No derivative securities were reported.
The filing signals a modest reduction in insider ownership but the director retains a sizeable stake, maintaining alignment with shareholders.
FAQ
What is the current stock price of Carter Bankshares (CARE)?
What is the market cap of Carter Bankshares (CARE)?
